Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 28, 2007
     
PRESSURE BIOSCIENCES, INC.
(Exact Name of Registrant as Specified in its Charter)
     
MASSACHUSETTS
(State or Other Jurisdiction of Incorporation)
     
0-21615
  
04-2652826
(Commission File Number)
  
(IRS Employer Identification No.)
     
321 Manley Street, West Bridgewater, MA
  
02379
(Address of Principal Executive Offices)
  
(Zip Code)
     
(508) 580-1818
(Registrant’s Telephone Number, Including Area Code)
     
N/A
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 1.01  Entry into a Material Definitive Agreement

On June 28, 2007, Pressure BioSciences, Inc. (the “Company”) issued a press release to announce that it had placed an order for 40 Barocycler NEP2320 units from Source Scientific, LLC, the manufacturer of the Company's PCT instrumentation and disposables product line. The purchase price for the 40 Barocycler NEP2320 units is based upon a cost-plus arrangement. The units will be manufactured and shipped in accordance with an agreed upon timeline. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by this reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release dated June 28, 2007


 
2
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: June 29, 2007
PRESSURE BIOSCIENCES, INC.
     
     
     
 
By:
 /s/ Edward H. Myles
 
Edward H. Myles,
 
Senior Vice President of Finance
 
& Chief Financial Officer
 

 
3
 


EXHIBIT INDEX


Exhibit
Number
Exhibit Description
99.1
Press Release dated June 28, 2007
 



 
4